Welcome

The Vermont Center on Behavior and Health (VCBH), led by Director Stephen T. Higgins, PhD, is an interdisciplinary research center committed to investigating relationships between personal behavior patterns (i.e., lifestyle) and risk for chronic disease and premature death. Our work has historically focused on health disparities for the most vulnerable populations, particularly among the socioeconomically disadvantaged where these risk factors are overrepresented.

 

VCBH logo

Located in Burlington, VT at the University of Vermont, Larner College of Medicine, VCBH researchers have a specific focus on understanding mechanisms underpinning risk and developing effective interventions and policies to promote healthy behavior. A common thread across VCBH research projects is the application of knowledge from the disciplines of behavioral economics and behavioral pharmacology to increase understanding of vulnerability to unhealthy behavior and the use of incentives and other behavioral and pharmacological interventions to support healthy behavior change interventions and policies.

Stay Connected with VCBH

Join our mailing list to get the latest
on news and events.

Follow us on our social media channels

Twitter icon circle Facebook icon circle LinkedIn icon YouTube Icon

Upcoming VCBH Events

Monthly Lecture Series:

November 20:
Joseph McClernon, PhD
Duke University

December 18:
Hugh Garavan, PhD
University of Vermont

Visit the Center on Rural Addiction

CORA_transparents

 


VCBH Career Opportunities

Postdoctoral Research Fellowships
Click here for more information.

VCBH News

Higgins and Colleagues Publish New UVM Tobacco Center of Regulatory Science (TCORS) Study in JAMA Network Open

September 12, 2024 by Stephen T. Higgins, PhD

This study examined whether e-cigarettes in appealing flavors enhance the decreases in cigarette smoking achieved by reducing the nicotine content of combusted cigarettes to minimally addictive levels.

This study examined whether e-cigarettes in appealing flavors enhance the decreases in cigarette smoking achieved by reducing the nicotine content of combusted cigarettes to minimally addictive levels (https://jamanetwork.com/journals/jamanetworkopen/article-abstract/2823300#google_vignette). In three Randomized Clinical Trials, decreases in cigarettes smoked daily achieved with reduced nicotine content cigarettes were significantly enhanced by providing adults from at-risk populations access to e-cigarettes in appealing flavors. These results suggest that a tobacco marketplace providing adult access to e-cigarettes in appealing flavors has potential to enhance the impact of a nicotine-reduction policy on cigarette smoking in populations with psychiatric conditions and socioeconomic disadvantage who are at greatest risk for smoking and associated adverse effects.

Read full story at JAMA Network Open